it involves the regulatory authorities of Australia (Therapeutic Goods Administration (TGA)), Canada (Health Canada), Singapore (Health Sciences Authority (HSA)), Switzerland (Swissmedic), and ...
Announced plans for new, state-of-the-art cell therapy R&D facility in Philadelphia Cash and cash equivalents, and time deposits of $1.2 billion, as of September 30, 2024, which Legend Biotech ...
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.